CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial

NCT06949800 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

HSIL, High Grade Squamous Intraepithelial Lesion
HPV-Related Squamous Cell Carcinoma
Anal HSIL

Interventions

DRUG: EXE-346 Probiotic
DRUG: Placebo
PROCEDURE: Usual Care High Resolution Anoscopy (HRA)

Sponsor

University of California, San Francisco

Collaborators

[object Object]
[object Object]